ACQUISITION OF ABACUS HEALTH - Narrative (Details) $ in Thousands		12 Months Ended
	Jun. 11, 2020 USD ($) shares	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Harmony Hemp
Business Acquisition [Line Items]
Asset acquisition, consideration payable		$ 144	$ 770
Customer Relationships
Business Acquisition [Line Items]
Estimated useful life		10 years
Tradenames
Business Acquisition [Line Items]
Estimated useful life		10 years
Abacus Health
Business Acquisition [Line Items]
Pro forma revenue			99,341,000
Pro forma net loss			(47,810,000)
One-time acquisition costs			$ 3,897,000
Share issuance ratio	0.85
Liabilities incurred	$ 7,251,000
Liabilities incurred, SARs	293,000
Liabilities incurred, warrants	$ 2,857,000
Estimated useful life	10 years
Abacus Health | Customer Relationships
Business Acquisition [Line Items]
Acquired intangible assets	$ 22,700,000
Abacus Health | Tradenames
Business Acquisition [Line Items]
Acquired intangible assets	$ 700,000
Abacus Health | Common shares
Business Acquisition [Line Items]
Equity issued (in shares) | shares	18,456,302
Abacus Health | Other Equity Instruments [Member]
Business Acquisition [Line Items]
Equity issued (in shares) | shares	3,884,986